Amidst the global cold war between Next Gen Pharma and the rest of the world, a small company managed to strike an unprecedented deal and secured partnerships to distribute the cure on an exclusive basis.
The conference room was a sleek amalgamation of modern design and cutting-edge technology, reflecting the high-stakes negotiations taking place within.
Steven Hook, the CEO of Pears, sat at the head of a polished, long oak table, His tailored suit and sharp demeanor exuded authority, but a hint of tension flickered in his steely gaze as he reviewed a series of documents on a holographic display.
The door opened, and a man stepped in, his stride confident and his face adorned with a friendly smile.
"Mr. Daniel Biswas!"
"Ah, Mr. Hook," Daniel greeted warmly, extending his hand. "It's good to finally meet you in person. Video calls just don't capture the same atmosphere."